thiosemicarbazone also called triapine substance studied treatment cancer belongs family drugs called ribonucleotide reductase potent inhibitor ribonucleotide reductase rate determining enzyme supply deoxynucleotides dna building blocks dna synthesis dna synthesis required cellular proliferation dna repair strong iron chelator body likely iron chelate active species quenches active site tyrosyl radical required ribonucleotide reductase enzymatic activity iron chelate redox active several reports literature ascribing property biological activities chosen based results studying screening products candidate inhibitor likely express activity setting human neoplastic disease vion pharmaceuticals also filed several use patents concerning antiviral antifungal activity initially developed vion pharmaceuticals company declared bankruptcy december nanotherapeutics inc acquired product bankruptcy supported trials nci product transferred nanoshift llc nanoshift llc nanopharmaceutics inc continue support clinical studies nci